Rare Xq23 Microdeletion Involving the DCX and PAK3 Genes Presenting With Lissencephaly, Agenesis of the Corpus Callosum, and Intractable Epilepsy: A Case Report.
- 1Medicine and Surgery, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR.
- 2School of Medicine, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR.
- 3Pediatric Neurology, Bahrain Defence Force Hospital, Riffa, BHR.
Abstract
X-linked lissencephaly spectrum disorder is a rare neurodevelopmental condition resulting from pathogenic variants that disrupt normal neuronal migration, with doublecortin (DCX) being one of the genes most frequently implicated. Similarly, pathogenic variants of the p21-activated kinase 3 (PAK3) gene are associated with X-linked syndromic intellectual disability, developmental delay, and epilepsy. Contiguous deletions involving both genes are exceedingly uncommon and may present with a complex neurological phenotype. We report the case of a seven-month-old male with intellectual disability, global developmental delay, intractable epilepsy with generalized-onset seizures, lissencephaly, agenesis of the corpus callosum, hypertonia, hyperreflexia, gastroesophageal reflux, and constipation. Brain magnetic resonance imaging (MRI) demonstrated structural brain abnormalities, while whole exome sequencing (WES) with copy number variant (CNV) analysis identified a pathogenic hemizygous 258-kb deletion at Xq23 (110395597_110654202)x0), encompassing the DCX gene and partially involving the PAK3 gene. This report aims to expand the current limited understanding of the clinical manifestations associated with Xq23 microdeletions involving DCX and PAK3. It also highlights the importance of advanced genetic testing in children presenting with developmental delay, epilepsy, and structural brain abnormalities, allowing for early diagnosis, appropriate genetic counseling, and, ultimately, improved patient care.
Related
- Triangular array progressions for population count models involving Markov-P\'{o}lya distributions and relatives
- The First Case of Digenic MODY Diabetes Involving Compound Heterozygosity of Three Variants in the PDX1 and HNF1B Genes
- Specification of bone marrow sinusoids requires TIE2-mediated positive feedback involving COUP-TFII and VEGFR3
- PDE10A identified by cross-hemisphere visual cortex proteomics restores adult ocular dominance plasticity involving cAMP/CREB signaling
- An Apoptotic Failsafe Program Involving PDGF-dependent PI 3-Kinase Activity Contributes to Plaque Composition in Atherosclerosis
BibTeX
@article{safar2026rare,
title = {{Rare Xq23 Microdeletion Involving the DCX and PAK3 Genes Presenting With Lissencephaly, Agenesis of the Corpus Callosum, and Intractable Epilepsy: A Case Report.}},
author = {Dora H Safar and Zahraa F Attaa and Fatima Atieh and Raafat Hamad Seroor H Jadah},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116506},
url = {https://europepmc.org/article/MED/42894868},
note = {CC BY},
}
RIS
TY - JOUR
TI - Rare Xq23 Microdeletion Involving the DCX and PAK3 Genes Presenting With Lissencephaly, Agenesis of the Corpus Callosum, and Intractable Epilepsy: A Case Report.
AU - Dora H Safar
AU - Zahraa F Attaa
AU - Fatima Atieh
AU - Raafat Hamad Seroor H Jadah
PY - 2026
DA - 2026/09/18
JO - Cureus
DO - 10.7759/cureus.116506
UR - https://europepmc.org/article/MED/42894868
AB - X-linked lissencephaly spectrum disorder is a rare neurodevelopmental condition resulting from pathogenic variants that disrupt normal neuronal migration, with doublecortin (DCX) being one of the genes most frequently implicated. Similarly, pathogenic variants of the p21-activated kinase 3 (PAK3) gene are associated with X-linked syndromic intellectual disability, developmental delay, and epilepsy. Contiguous deletions involving both genes are exceedingly uncommon and may present with a complex neurological phenotype. We report the case of a seven-month-old male with intellectual disability, global developmental delay, intractable epilepsy with generalized-onset seizures, lissencephaly, agenesis of the corpus callosum, hypertonia, hyperreflexia, gastroesophageal reflux, and constipation. Brain magnetic resonance imaging (MRI) demonstrated structural brain abnormalities, while whole exome sequencing (WES) with copy number variant (CNV) analysis identified a pathogenic hemizygous 258-kb deletion at Xq23 (110395597_110654202)x0), encompassing the DCX gene and partially involving the PAK3 gene. This report aims to expand the current limited understanding of the clinical manifestations associated with Xq23 microdeletions involving DCX and PAK3. It also highlights the importance of advanced genetic testing in children presenting with developmental delay, epilepsy, and structural brain abnormalities, allowing for early diagnosis, appropriate genetic counseling, and, ultimately, improved patient care.
SN - 2168-8184
ER -